Inventor · Carlsbad, CA, US

Peng Wang

49Patents
5h-index
121Co-inventors
72Inventor score

Filing activity: Jan 11, 1997 → Feb 5, 2024

Most-cited inventions

PatentTitleAreaCited byStatus
US5861279A Baculovirus expression system for human interleukin 5 receptor and method of screening for interleukin 5 antagonists Chemistry; Metallurgy 83 Expired
US8765948B2 Processes for the preparation of uracil derivatives Human Necessities 19 Active
US9382214B2 Processes for the preparation of uracil derivatives Human Necessities 18 Active
US9650442B2 Bispecific anti-EGFR/anti IGF-1R antibodies Chemistry; Metallurgy 14 Active
US6867194B2 Enzyme activated nitric oxide donors Human Necessities 8 Expired
US9868706B2 Processes for the preparation of uracil derivatives Human Necessities 5 Active
US11266647B2 Method for increasing cell proliferation in pancreatic beta cells, treatment method, and composition Chemistry; Metallurgy 5 Active
US11111295B2 Antibody for anti-claudin 18A2 and use thereof Chemistry; Metallurgy 4 Active
US10793641B2 Fully human anti-mesothelin antibodies and immune effector cells targeting mesothelin Chemistry; Metallurgy 4 Active
US6329378A Hydrazone, hydrazine and thiosemicarbazone derivatives as antifungal agents Chemistry; Metallurgy 4 Expired
US10995099B2 Compounds and their uses as ACC inhibitors Chemistry; Metallurgy 3 Active
US11180506B2 KRAS mutant protein inhibitors Chemistry; Metallurgy 3 Active
US6846923B2 Oxime-linked polysaccharides and methods of preparing the same Textiles; Paper 3 Expired
US8873845B2 Contextual dominant color name extraction Physics 2 Active
US11447570B2 Binding unit targeting fibroblast activation protein α and application thereof Chemistry; Metallurgy 2 Active
US11788064B2 Method of increasing proliferation of pancreatic beta cells, treatment method, and composition Chemistry; Metallurgy 1 Active
US11866427B2 Kinase inhibitor compounds and compositions and methods of use Human Necessities 1 Active
US11161847B2 KRAS mutant protein inhibitors Chemistry; Metallurgy 1 Active
US10221134B2 Processes to produce brivaracetam Chemistry; Metallurgy 1 Active
US10494347B2 Processes for the preparation of uracil derivatives Human Necessities 1 Active
US11459305B2 Processes for the preparation of uracil derivatives Human Necessities 1 Active
US11525006B2 BCMA-targeting antibody and use thereof Chemistry; Metallurgy 1 Active
US11161851B2 Processes to produce acalabrutinib Chemistry; Metallurgy 1 Active
US11427633B2 Anti-CD19 humanized antibody and immune effector cell targeting cd 19 Chemistry; Metallurgy 0 Active
US12195473B2 KRAS mutant protein inhibitors Chemistry; Metallurgy 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.